Release Therapeutics

Release Therapeutics is a biomedical technology company that plans to develop the first cellular microencapsulation technology. The company provides effective therapeutic proteins that cross the human blood-brain barrier, combining an implantable microcapsule device with an immortalized myoblast cell line capable of producing multiple proteins for long-term delivery to the central nervous system (CNS). This helps medical professionals explore new therapies for genetic and severe diseases using patented encapsulated cell technology, enhancing CNS function and enabling versatile applications for life.